Publications by authors named "Vendela Parrow"

Claim this Profile
P
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.
Nadilly Bonagas, Nina M S Gustafsson, Martin Henriksson, Petra Marttila, Robert Gustafsson, Vendela Parrow

Nat Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.
Claes R Andersson, Tove Selvin, Kristin Blom, Jenny Rubin, Malin Berglund, Vendela Parrow

Sci Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition.
Kristin Blom, Jenny Rubin, Malin Berglund, Malin Jarvius, Lena Lenhammar, Vendela Parrow

BMC Res Notes· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
Kristin Blom, Wojciech Senkowski, Malin Jarvius, Malin Berglund, Jenny Rubin, Vendela Parrow

Immunopharmacol Immunotoxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism.
Ahmed Waraky, Karen Akopyan, Vendela Parrow, Thomas Strömberg, Magnus Axelson

Oncotarget· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.
Anna Eriksson, Antonia Kalushkova, Malin Jarvius, Riet Hilhorst, Linda Rickardson, Vendela Parrow

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia.
Anna Eriksson, Martin Höglund, Elin Lindhagen, Anna Aleskog, Sadia Bashir Hassan, Vendela Parrow

Biochem Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo evaluation of a novel, orally bioavailable, small molecule growth hormone receptor antagonist.
Linda Rosengren, Vendela Parrow, Joanna Chmielewska, Agneta Mode, Karin Fhölenhag

Growth Horm IGF Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense and sense RNA probe hybridization to immobilized crude cellular lysates: a tool to screen growth hormone antagonists.
Linda Rosengren, Hanna Simko, Ladan Aryan, Pia Axelsson-Lendin, Joanna Chmielewska, Vendela Parrow

J Biomol Screen· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis